PTC Therapeutics, Inc. (PTCT)
65.49
+0.34
(+0.52%)
USD |
NASDAQ |
May 04, 16:00
65.48
-0.02
(-0.02%)
After-Hours: 20:00
PTC Therapeutics Market Cap : 5.421B for May 4, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Sarepta Therapeutics, Inc. | 2.314B |
| Keros Therapeutics, Inc. | 230.89M |
| Insmed, Inc. | 30.18B |
| Madrigal Pharmaceuticals, Inc. | 11.90B |
| Protagonist Therapeutics, Inc. | 6.350B |
Market Cap Related Metrics
| PE Ratio | 8.465 |
| PS Ratio | 3.144 |
| Price to Free Cash Flow | 13.23 |
| Price | 65.49 |
| Earnings Yield | 11.81% |
| Operating PE Ratio | 6.353 |
| Normalized PE Ratio | 8.565 |